Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Congressionally Directed Medical Research Programs
Grant: HT94252310910
Grant: 5P01CA163227
Grant: 1S10OD036228-01
NIH HHS
Grant: S10 OD036228
Fields of Study
Keywords